6 quiz questions available for this topicTake Quiz
Gastrointestinal tract (upper) cancers - recognition and referral
💡
Exam Tips
- In UK exams, know referral triggers precisely: dysphagia -> urgent 2-week upper GI endoscopy; jaundice age >= 40 -> suspected pancreatic cancer pathway.
- For age >= 60 with weight loss plus back pain/abdominal pain/change in bowel habit/nausea-vomiting/constipation/new diabetes, think pancreatic cancer and request urgent CT (or ultrasound if CT unavailable).
- Thrombocytosis and low haemoglobin are important supportive clues in older patients with upper abdominal symptoms; they increase suspicion even when symptoms seem non-specific.
- Avoid the common OSCE pitfall of prolonged empirical PPI management in alarm-feature patients; urgent investigation takes priority.
- Anatomy-image anchor: review a diagram of the pancreatic head and distal bile duct relationship to explain painless jaundice in pancreatic head tumours (see hepatobiliary anatomy figure in your core surgery text).
Definition
Upper gastrointestinal tract cancer in UK referral practice includes suspected malignancy of the oesophagus, stomach, pancreas, liver, gallbladder, and (rarely) small bowel presenting in primary care with alarm symptoms rather than screening-detected disease. The core clinical task is early recognition of red-flag symptom patterns and age thresholds, followed by urgent site-appropriate investigation (usually 2-week-wait endoscopy, CT, or ultrasound) to secure rapid tissue diagnosis in secondary care.
Pathophysiology
These cancers arise through multistep genetic and inflammatory injury pathways that convert dysplasia to invasive carcinoma. Typical mechanisms include reflux-driven Barrett metaplasia progressing to oesophageal adenocarcinoma, chronic Helicobacter pylori gastritis leading to gastric atrophy/intestinial metaplasia and gastric adenocarcinoma, chronic pancreatitis/smoking-related mutations in pancreatic ductal cells, and cirrhosis-related hepatocellular carcinogenesis (for example after viral hepatitis or alcohol-related liver disease). Clinical manifestations reflect local invasion (dysphagia, gastric outlet symptoms, biliary obstruction), systemic effects (weight loss, anorexia, anaemia, thrombocytosis as a paraneoplastic marker), and metastatic spread.
Risk Factors
- Increasing age (especially >= 55 years for upper GI endoscopy symptom thresholds; >= 60 years for pancreatic imaging thresholds)
- Male sex (higher incidence for oesophageal and stomach cancer)
- Smoking
- Alcohol excess (particularly with chronic liver disease risk)
- Barrett's oesophagus and chronic gastro-oesophageal reflux disease
- Helicobacter pylori-associated chronic gastritis/atrophy
- Obesity
- Chronic pancreatitis
- New-onset diabetes in older adults (can be a marker of pancreatic cancer)
- Cirrhosis from chronic hepatitis B/C or alcohol-related liver disease
- Gallstone disease/chronic gallbladder inflammation
- Family history or hereditary cancer syndromes (for example Lynch syndrome, hereditary diffuse gastric cancer, familial pancreatic cancer)
Clinical Features
Symptoms
- Progressive dysphagia (solids then liquids)
- Unintentional weight loss
- Persistent upper abdominal or epigastric pain
- Reflux or treatment-resistant dyspepsia
- Nausea and/or vomiting
- Haematemesis
- Back pain with weight loss (notably pancreatic pattern)
- Change in bowel habit with weight loss in older adults
- New-onset diabetes with weight loss (age >= 60 years)
- Jaundice (especially age >= 40 years, urgent pancreatic pathway)
- Appetite loss
Signs
- Upper abdominal mass (enlarged gallbladder or liver)
- Hepatomegaly
- Visible jaundice/scleral icterus
- Pallor from iron-deficiency or anaemia of chronic disease
- Cachexia/sarcopenia
- Abdominal tenderness or fullness
- Signs of chronic liver disease in hepatocellular carcinoma risk patients
Investigations
Urgent direct-access upper GI endoscopy (within 2 weeks):Visible oesophageal or gastric lesion with biopsy-confirmed malignancy; indicated for dysphagia or age >= 55 years with weight loss plus upper abdominal pain/reflux/dyspepsia
Non-urgent direct-access upper GI endoscopy:May detect upper GI cancer in haematemesis or age >= 55 years with treatment-resistant dyspepsia, thrombocytosis-associated upper GI symptoms, or low haemoglobin with upper abdominal pain
Suspected cancer pathway referral (pancreas) for jaundice in age >= 40 years:Expedited specialist assessment for likely obstructive pancreaticobiliary malignancy
Urgent pancreas-protocol CT (within 2 weeks) or ultrasound if CT unavailable:Pancreatic mass, duct dilatation, local invasion, nodal or metastatic disease; used for age >= 60 years with weight loss plus diarrhoea/back pain/abdominal pain/nausea/vomiting/constipation/new-onset diabetes
Urgent abdominal ultrasound (within 2 weeks) for upper abdominal mass:Mass compatible with enlarged gallbladder, liver lesion, biliary dilatation, or other hepatobiliary abnormality requiring onward biopsy/staging
Core bloods in primary care (FBC, platelets, LFTs, U&Es, glucose or HbA1c):Anaemia, thrombocytosis, cholestatic LFT pattern, or new dysglycaemia supporting urgency and helping differential diagnosis
Histology/cytology from endoscopic or image-guided biopsy (secondary care):Definitive diagnosis and tumour subtype confirmation
Management
Lifestyle Modifications
- Do not delay urgent referral while trialling prolonged empirical therapy if red flags are present
- Safety-net clearly: advise immediate review for worsening dysphagia, vomiting, GI bleeding, jaundice, dehydration, or rapid weight loss
- Smoking cessation support and alcohol reduction
- Early dietetic input for high-calorie/high-protein intake and hydration while awaiting specialist care
- Discuss fitness, comorbidity optimisation, and goals of care early
Pharmacological Treatment
Acid suppression for troublesome reflux/dyspepsia symptoms while awaiting investigation
- Omeprazole 20 mg orally once daily (short symptomatic course)
Use only as symptom control; do not allow PPI response to defer indicated urgent endoscopy. Check interactions (for example reduced clopidogrel activation risk discussion) and review need promptly.
Analgesia
- Paracetamol 1 g orally up to four times daily (max 4 g/day)
First-line for pain. In liver impairment, frailty, low body weight, or alcohol excess, reduce maximum daily dose and monitor.
Antiemetic
- Cyclizine 50 mg orally up to three times daily as required
Can help nausea while awaiting urgent work-up. Caution in severe heart failure and glaucoma; may cause sedation/anticholinergic adverse effects.
Iron replacement for confirmed iron-deficiency anaemia (if tolerated)
- Ferrous sulfate 200 mg tablet (about 65 mg elemental iron) once daily
Treats anaemia symptoms but does not replace cancer investigation. Counsel on constipation/dark stools and keep out of reach of children (toxicity risk in overdose).
Pancreatic exocrine insufficiency support (specialist-guided if pancreatic cancer confirmed)
- Pancreatin (Creon 25,000 units lipase) with meals, titrated to symptoms and fat content
Improves steatorrhoea and weight maintenance in pancreatic disease. Swallow capsules whole or open into acidic soft food; do not crush/chew.
Surgical / Interventional
- Oesophagectomy for selected localised oesophageal cancer
- Partial or total gastrectomy for resectable gastric cancer
- Pancreaticoduodenectomy (Whipple) or distal pancreatectomy for operable pancreatic tumours
- Hepatic resection or local ablative therapy for selected primary liver cancers
- Cholecystectomy with oncological resection for selected gallbladder cancers
- Endoscopic or radiological stenting/bypass procedures for palliation of obstruction
Complications
- Malnutrition and cancer cachexia
- Upper GI bleeding and iron-deficiency anaemia
- Biliary obstruction with cholangitis risk
- Gastric outlet or oesophageal obstruction causing dehydration/aspiration
- Venous thromboembolism
- Metastatic spread (liver, peritoneum, lung, bone)
- Hepatic decompensation in underlying cirrhosis
- Poor glycaemic control or diabetes-related complications in pancreatic disease
Prognosis
Overall outcomes remain poor because many cases present late. Approximate 5-year survival: oesophageal around 15%, stomach around 20%, pancreatic below 5%, gallbladder just over 10%, and primary liver cancer around 15%. Earlier stage at diagnosis and eligibility for curative resection are the strongest determinants of improved survival.
Sources & References
✅NICE Guidelines(1)
📖Textbook References(20)
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 399)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 258, 259)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 809)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 827)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 971)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 827)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 971)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 809)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1006, 1007)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 219, 220)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1007)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1044)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 220)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1012, 1013)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1062, 1063)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1064, 1065)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 213, 214)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 68, 69)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1063)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1063, 1064)[context]